FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Related Tags >> ovarian cancer vaccine
Syndicate content

Prima BioMed News

Most Popular Prima BioMed Story

Prima BioMed to raise cash for ovarian cancer vaccine trial

Australia's Prima BioMed plans to raise AU$38 million to fund late-stage trials of CVac, an immunotherapy ovarian cancer vaccine designed to be administered post-surgery and post-chemotherapy to Read more...

Latest Headlines